lapatinib has been researched along with proquazone in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (proquazone) | Trials (proquazone) | Recent Studies (post-2010) (proquazone) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 48 | 15 | 2 |
| Protein | Taxonomy | lapatinib (IC50) | proquazone (IC50) |
|---|---|---|---|
| Prostaglandin-H2 D-isomerase | Mus musculus (house mouse) | 0.07 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.07 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.07 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.002 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansal, R; Malhotra, A | 1 |
1 review(s) available for lapatinib and proquazone
| Article | Year |
|---|---|
Therapeutic progression of quinazolines as targeted chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms; Quinazolines | 2021 |